|
December 17, 2007: Baxter Announces FDA Approval of GELFOAM® Plus Hemostasis Kit
December 03, 2007: Baxter Introduces New Drug Safety Packaging for High Alert Medications
November 27, 2007: U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC's DVC and Baxter
November 13, 2007: Baxter Declares Quarterly Dividend, Increases Rate 30 Percent
November 09, 2007: Baxter Receives 510(k) Clearance from FDA for V-Link with VitalShield, New Antimicrobial Intravascular Technology
November 06, 2007: Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
November 05, 2007: Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
November 02, 2007: Baxter Announces 2007 Renal Discoveries Grant Winners
November 01, 2007: New Study Finds ADEPT® Effective in Reducing Adhesions Following Gynecological Laparoscopic Surgery
October 18, 2007: Baxter Reports Strong Third Quarter Sales and Earnings
October 16, 2007: Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
October 09, 2007: Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
September 12, 2007: Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
September 10, 2007: Baxter and Halozyme Announce Collaboration For Development Of Subcutaneous GAMMAGARD LIQUID™ Administration using Enhanze™ Technology
August 28, 2007: Baxter and the Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients with Alzheimer's Disease
August 22, 2007: Baxter to Launch GARDian™, a Groundbreaking Initiative that Helps Provide Continued Access to GAMMAGARD for Current Patients
August 16, 2007: Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
August 08, 2007: Baiyunshan Pharmaceutical and Baxter Finalize Joint Venture for Parenteral Nutrition Products in China
August 07, 2007: Baxter Provides Update on Service Documentation Class I Recall
August 06, 2007: Baxter Announces Collaboration for Development of Next-Generation Home Hemodialysis Machine
August 02, 2007: Baxter Releases Eighth Annual Sustainability Report
August 01, 2007: Baxter International Inc. Names Wayne Hockmeyer to Board of Directors
July 31, 2007: Baxter Declares Quarterly Dividend
July 25, 2007: FDA Classifies Baxter´s Voluntary Recall Action Regarding Service Documentation as a Class I Recall
July 19, 2007: Baxter Raises 2007 Earnings Guidance Following Strong Second Quarter Financial Results
July 18, 2007: FDA Classifies Baxter´s Field Corrective Action as a Class I Recall on Recently Manufactured or Upgraded COLLEAGUE Triple Channel Infusion Pumps (Models 2M8153, 2M8163 and 2M9163)
July 12, 2007: Baxter Announces Preliminary Phase I/II Data for Seasonal Influenza Vaccine Candidate
June 20, 2007: Baxter Signs Agreements to Evaluate TISSEEL use with New, Innovative Therapies
June 13, 2007: Baxter Supports Improved Access to Pandemic Influenza Treatment in the Developing World
May 09, 2007: Baxter Receives Approval to Process ARALAST NP
May 01, 2007: Baxter Executives Provide Update on Progress at Annual Shareholder Meeting
April 27, 2007: Baxter Introduces HYLENEX for use in Ophthalmic Surgery
April 25, 2007: Baxter Announces Carbon Neutral Headquarters
April 25, 2007: SPEECH: Contributing to a More Sustainable World: A Common Purpose
April 20, 2007: Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
April 19, 2007: Baxter Reports Strong First Quarter Financial Results and Boosts Full-Year Outlook
April 17, 2007: Baxter Continues Its Support of the World Federation of Hemophilia's Global Alliance for Progress Program
March 30, 2007: Baxter Announces FDA Approval of CEPROTIN for Severe Congenital Protein C Deficiency
March 29, 2007: Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
March 27, 2007: Baxter Announces 2007 Renal Discoveries Grant Program to Advance Science and Care for Kidney Disease Patients
March 14, 2007: Baxter Holds 2007 Investor Conference in Chicago
March 13, 2007: Baxter's Board of Directors Expands Share Repurchase Authorization by $2 Billion
March 09, 2007: Baxter Initiates Multi-Center Phase II Clinical Trial to Manage Fluid Overload in Congestive Heart Failure Patients
March 06, 2007: Baxter and its Foundation Contribute More Than $35 Million in 2006 to Address Local and Global Critical Needs
March 01, 2007: Baxter Completes Sale of Transfusion Therapies Business
February 27, 2007: Baxter Receives 510(K) Clearance from FDA for COLLEAGUE Infusion Pumps
February 15, 2007: Baxter Recognized As Sustainability Leader by Innovest and Corporate Responsibility Officer Magazine
February 14, 2007: Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
February 14, 2007: Halozyme And Baxter Expand Global HYLENEX Collaboration
February 13, 2007: Baxter Names Robert Hombach Treasurer
February 13, 2007: Baxter Declares Quarterly Dividend and Increases Annual Rate by 15 Percent
February 09, 2007: Two Baxter Facilities Recognized With Shingo Prize for Excellence in Manufacturing
February 07, 2007: Baxter Continues Collaborations With Global Health Authorities To Advance Pandemic Preparedness
February 07, 2007: Donald M. Berwick, MD, MPP, Selected as 2007 Recipient of The William B. Graham Prize for Health Services Research
February 06, 2007: Baxter Receives Clearance From U.S. FDA for Ipump Pain Management System 510(k)
January 25, 2007: Baxter's Fourth Quarter Financial Results Exceed Expectations
January 24, 2007: Memorial Healthcare System in Hollywood, Florida Receives Prestigious Foster G. McGaw Award for Excellence in Community Service
January 18, 2007: CSC’s DVC and Baxter Begin Phase 1 Clinical Trial for Chemical Defense Product
|
Print this page
